Fujitsu launched a new cloud-based platform that allows users to securely collect and leverage health-related data.
The new platform automatically converts medical data from medical institutions' electronic medical records to conform with the next-generation standards framework HL7 FHIR,
Consenting patients can securely store personal health information such as vital data, step counts, and calorie consumption.
These are converted into non-personally identifiable information on the platform, which supports medical institutions and pharmaceutical companies in performing data analysis and R&D activities.
The new offering represents Fujitsu’s ongoing efforts to promote digital transformation in the medical field and contribute to the creation of a healthy society.
Fujitsu will also use the platform to develop a data portability service that enables patients to view their medical data on their smartphones and allows medical institutions to conduct a highly accurate analysis of shared medical data on the platform.
Fujitsu said it aims to leverage this platform to realize an AI and IoT-based preventive healthcare system and cooperate with various medical institutions and companies to realize a digital health ecosystem.


US Auto Industry Urges Trump to Block Chinese EV Market Access
US, Japan Reaffirm Strong Currency Coordination Amid Yen Volatility
Armani Group Eyes Strategic Stake Sale to Luxury Giants
Samsung Shares Slide as Labor Talks Intensify Ahead of Planned Strike
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases
Trump Says Iran Ceasefire ‘On Life Support’ as Oil Prices Surge Above $104
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping
Kuaishou Stock Jumps on Kling AI IPO Plans and $20 Billion Valuation
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 



